Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Heart, kidneys, liver: Helps decrease inflammation, oxidative stress, and fat buildup
The primary objectives of this study are to evaluate the effect of elafibranor (120 mg/day) treatment in NASH patients (NAS 4) with stage 2/3 fibrosis compared to placebo on (1) histological improvement and (2) all-cause mortality and liver-related outcomes in patients with NASH and fibrosis
higher m ) in mutant FoB (Fig
doi: 10.1016/j.immuni.2014.02.009 46 ImDS
10.1016/j.ebiom.2021.103242 25 MaoX.XuJ.WangW.LiangC.HuaJ.LiuJ.et al (2021)
doi: 10.1016/j.procir.2013.01.042 118
US$ 20.15
US$ 24.74
US$ 28.08
US$ 21.69
US$ 23.40
US$ 29.06
US$ 22.28
US$ 26.88
US$ 28.68
US$ 22.42
